{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:17:37Z","timestamp":1793089057687,"version":"4.5.0"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T00:00:00Z","timestamp":1511481600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s12020-017-1438-7","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T06:46:47Z","timestamp":1511506007000},"page":"16-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Prolactinoma through the female life cycle"],"prefix":"10.1007","volume":"59","author":[{"given":"Deirdre","family":"Cocks Eschler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Javanmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza B.","family":"Geer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,24]]},"reference":[{"key":"1438_CR1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJM198101153040306","volume":"304","author":"GN Burrow","year":"1981","unstructured":"G.N. Burrow, G. W., N.B. Rewcastle, R.C. Holdgate, K. Kovacs, Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N. Engl. J. Med. 304, 156\u2013158 (1981)","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"1438_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11102-005-5083-4","volume":"8","author":"MD Bronstein","year":"2005","unstructured":"M.D. Bronstein, Prolactinomas and pregnancy. Pituitary 8(1), 31\u201338 (2005). https:\/\/doi.org\/10.1007\/s11102-005-5083-4","journal-title":"Pituitary"},{"issue":"5","key":"1438_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"M.P. Gillam, M.E. Molitch, G. Lombardi, A. Colao, Advances in the treatment of prolactinomas. Endocr. Rev. 27(5), 485\u2013534 (2006). https:\/\/doi.org\/10.1210\/er.2005-9998","journal-title":"Endocr. Rev."},{"issue":"5","key":"1438_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.beem.2009.05.003","volume":"23","author":"A Colao","year":"2009","unstructured":"A. Colao, Pituitary tumours: the prolactinoma. Best Pract. Res. 23(5), 575\u2013596 (2009). https:\/\/doi.org\/10.1016\/j.beem.2009.05.003","journal-title":"Best Pract. Res."},{"issue":"12","key":"1438_CR5","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1210\/jc.2006-1668","volume":"91","author":"AF Daly","year":"2006","unstructured":"A.F. Daly, M. Rixhon, C. Adam, A. Dempegioti, M.A. Tichomirowa, A. Beckers, High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J. Clin. Endocrinol. Metab. 91(12), 4769\u20134775 (2006). https:\/\/doi.org\/10.1210\/jc.2006-1668","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9138","key":"1438_CR6","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/S0140-6736(98)03356-X","volume":"352","author":"A Colao","year":"1998","unstructured":"A. Colao, G. Lombardi, Growth-hormone and prolactin excess. Lancet 352(9138), 1455\u20131461 (1998). https:\/\/doi.org\/10.1016\/S0140-6736(98)03356-X","journal-title":"Lancet"},{"issue":"3","key":"1438_CR7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2265.1994.tb02557.x","volume":"41","author":"T Mindermann","year":"1994","unstructured":"T. Mindermann, C.B. Wilson, Age-related and gender-related occurrence of pituitary adenomas. Clin. Endocrinol. 41(3), 359\u2013364 (1994)","journal-title":"Clin. Endocrinol."},{"issue":"7","key":"1438_CR8","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1210\/jcem.82.7.4088","volume":"82","author":"E Delgrange","year":"1997","unstructured":"E. Delgrange, J. Trouillas, D. Maiter, J. Donckier, J. Tourniaire, Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J. Clin. Endocrinol. Metab. 82(7), 2102\u20132107 (1997). https:\/\/doi.org\/10.1210\/jcem.82.7.4088","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"1438_CR9","first-page":"95","volume":"39","author":"M Guibout","year":"1978","unstructured":"M. Guibout, P. Jaquet, J.C. Lissitzky, F. Grisoli, F. Vincentelli, Transsphenoidal surgery in hypersecreting pituitary tumors: endocrine follow-up (author\u2019s transl). Ann. Endocrinol. 39(2), 95\u2013106 (1978)","journal-title":"Ann. Endocrinol."},{"key":"1438_CR10","unstructured":"K.L. Moore, T.V.N. Persaud, M.G. Torchia (eds.), Nervous system, The Developing Human: Clinically Oriented Embryology, (Saunders an imprint of Elsevier, Philadelphia, 2013), pp. 389\u2013427"},{"key":"1438_CR11","doi-asserted-by":"crossref","unstructured":"L. Cochard, The nervous system. in: Netter\u2019s Atlas of Human Embryology, Updated Edition, (Elsevier, 2012), pp. 51\u201381","DOI":"10.1016\/B978-1-4557-3977-6.00003-X"},{"issue":"12","key":"1438_CR12","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/j.1460-9568.2010.07523.x","volume":"32","author":"H Vankelecom","year":"2010","unstructured":"H. Vankelecom, Pituitary stem\/progenitor cells: embryonic players in the adult gland? Eur. J. Neurosci. 32(12), 2063\u20132081 (2010). https:\/\/doi.org\/10.1111\/j.1460-9568.2010.07523.x","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"1438_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1210\/er.2001-0030","volume":"23","author":"LE Cohen","year":"2002","unstructured":"L.E. Cohen, S. Radovick, Molecular basis of combined pituitary hormone deficiencies. Endocr. Rev. 23(4), 431\u2013442 (2002). https:\/\/doi.org\/10.1210\/er.2001-0030","journal-title":"Endocr. Rev."},{"key":"1438_CR14","doi-asserted-by":"crossref","unstructured":"S. Nussey, S. Whitehead (eds.), The pituitary gland, Endocrinology: An integrated approach (BIOS Scientific Publishers, Oxford, 2001)","DOI":"10.4324\/9780203450437"},{"issue":"1","key":"1438_CR15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1210\/jcem-63-1-156","volume":"63","author":"N Suganuma","year":"1986","unstructured":"N. Suganuma, H. S., N. Yamamoto, F. Kikkawa, O. Narita, Y. Tomoda, N. Matsui, Ontogenesis of pituitary prolactin in the human fetus. J. Clin. Endocrinol. Metab. 63(1), 156\u2013161 (1986)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Pt 20","key":"1438_CR16","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1242\/jcs.088500","volume":"124","author":"K Featherstone","year":"2011","unstructured":"K. Featherstone, C.V. Harper, A. McNamara, S. Semprini, D.G. Spiller, J. McNeilly, A.S. McNeilly, J.J. Mullins, M.R. White, J.R. Davis, Pulsatile patterns of pituitary hormone gene expression change during development. J. Cell Sci. 124(Pt 20), 3484\u20133491 (2011). https:\/\/doi.org\/10.1242\/jcs.088500","journal-title":"J. Cell Sci."},{"issue":"1","key":"1438_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1172\/JCI108064","volume":"56","author":"MJ Aubert","year":"1975","unstructured":"M.J. Aubert, M.M. Grumbach, S.L. Kaplan, The ontogenesis of human fetal hormones. III. Prolactin. J. Clin. Invest. 56(1), 155\u2013164 (1975). https:\/\/doi.org\/10.1172\/JCI108064","journal-title":"J. Clin. Invest."},{"issue":"4","key":"1438_CR18","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","volume":"80","author":"ME Freeman","year":"2000","unstructured":"M.E. Freeman, B. Kanyicska, A. Lerant, G. Nagy, Prolactin: structure, function, and regulation of secretion. Physiol. Rev. 80(4), 1523\u20131631 (2000)","journal-title":"Physiol. Rev."},{"issue":"2","key":"1438_CR19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1042\/bst0290038","volume":"29","author":"M Freemark","year":"2001","unstructured":"M. Freemark, Ontogenesis of prolactin receptors in the human fetus: roles in fetal development. Biochem. Soc. Trans. 29(2), 38\u201341 (2001)","journal-title":"Biochem. Soc. Trans."},{"key":"1438_CR20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1203\/00006450-197305000-00007","volume":"7","author":"HJ Guyda","year":"1973","unstructured":"H.J. Guyda, H.G. Friesen, Serum prolactin levels in humans from birth to adult life. Pediatr. Res. 7, 534\u2013540 (1973)","journal-title":"Pediatr. Res."},{"issue":"11-12","key":"1438_CR21","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1515\/jpem-2012-0130","volume":"25","author":"G Catli","year":"2012","unstructured":"G. Catli, A. Abaci, A. Altincik, K. Demir, S. Can, A. Buyukgebiz, E. Bober, Hyperprolactinemia in children: clinical features and long-term results. J. Pediatr. Endocrinol. Metab. 25(11-12), 1123\u20131128 (2012). https:\/\/doi.org\/10.1515\/jpem-2012-0130","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"1438_CR22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/oxfordjournals.epirev.a036232","volume":"3","author":"E Gold","year":"1981","unstructured":"E. Gold, Epidemiology of pituitary adenomas. Epidemiol. Rev. 3, 163\u2013183 (1981)","journal-title":"Epidemiol. Rev."},{"issue":"3","key":"1438_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11102-008-0149-8","volume":"12","author":"SV Acharya","year":"2009","unstructured":"S.V. Acharya, R.A. Gopal, T.R. Bandgar, S.R. Joshi, P.S. Menon, N.S. Shah, Clinical profile and long term follow up of children and adolescents with prolactinomas. Pituitary 12(3), 186\u2013189 (2009). https:\/\/doi.org\/10.1007\/s11102-008-0149-8","journal-title":"Pituitary"},{"issue":"2","key":"1438_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4274\/jcrpe.v3i2.14","volume":"3","author":"E Eren","year":"2011","unstructured":"E. Eren, S. Yapici, E.D. Cakir, L.A. Ceylan, H. Saglam, O. Tarim, Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases. J. Clin. Res. Pediatr. Endocrinol. 3(2), 65\u201369 (2011). https:\/\/doi.org\/10.4274\/jcrpe.v3i2.14","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"3","key":"1438_CR25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1515\/JPEM.2000.13.3.261","volume":"13","author":"HL Fideleff","year":"2000","unstructured":"H.L. Fideleff, H.R. Boquete, A. Sequera, M. Suraez, P. Sobrado, Peripubertal prolactinomas: clinical presentation and long-term outcome with different therapeutic approaches. J. Pediatr. Endocrinol. Metab. 13(3), 261\u2013267 (2000)","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"9","key":"1438_CR26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s12098-013-1266-6","volume":"81","author":"E Eren","year":"2014","unstructured":"E. Eren, H. Saglam, E.D. Cakir, O. Tarim, Etiological evaluation of adolescents with primary amenorrhea. Indian J. Pediatr. 81(9), 861\u2013865 (2014). https:\/\/doi.org\/10.1007\/s12098-013-1266-6","journal-title":"Indian J. Pediatr."},{"issue":"3","key":"1438_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","volume":"72","author":"A Fernandez","year":"2010","unstructured":"A. Fernandez, N. Karavitaki, J.A. Wass, Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin. Endocrinol. 72(3), 377\u2013382 (2010). https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03667.x","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"1438_CR28","first-page":"1135","volume":"79","author":"LA Kane","year":"1994","unstructured":"L.A. Kane, M. L, B.W. Scheithaueru, E.J. Bergstralh, E.R. Laws Jr, R.V. Groover, K. Kovacs, E. Horvath, D. Zimmerman, Pituitary adenomas in childhood and adolescence. J. Clin. Endocrinol. Metab. 79(4), 1135\u20131140 (1994)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"1438_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-12-0763","volume":"168","author":"T Cuny","year":"2013","unstructured":"T. Cuny, M. Pertuit, M. Sahnoun-Fathallah, A. Daly, G. Occhi, M.F. Odou, A. Tabarin, M.L. Nunes, B. Delemer, V. Rohmer, R. Desailloud, V. Kerlan, O. Chabre, J.L. Sadoul, M. Cogne, P. Caron, C. Cortet-Rudelli, A. Lienhardt, I. Raingeard, A.M. Guedj, T. Brue, A. Beckers, G. Weryha, A. Enjalbert, A. Barlier, Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don\u2019t forget MEN1 genetic analysis. Eur. J. Endocrinol. 168(4), 533\u2013541 (2013). https:\/\/doi.org\/10.1530\/EJE-12-0763","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"1438_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00381-006-0259-4","volume":"23","author":"M Mehrazin","year":"2007","unstructured":"M. Mehrazin, Pituitary tumors in children: clinical analysis of 21 cases. Childs Nerv. Syst. 23(4), 391\u2013398 (2007). https:\/\/doi.org\/10.1007\/s00381-006-0259-4","journal-title":"Childs Nerv. Syst."},{"issue":"2","key":"1438_CR31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1227\/00006123-199502000-00004","volume":"36","author":"T Mindermann","year":"1995","unstructured":"T. Mindermann, C.B. Wilson, Pediatric pituitary adenomas. Neurosurgery 36(2), 259\u2013268 (1995). discussion 269","journal-title":"Neurosurgery"},{"issue":"8","key":"1438_CR32","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1210\/jcem.83.8.5001","volume":"83","author":"A Colao","year":"1998","unstructured":"A. Colao, S. L., M. Cappa, A. Di Sarno, M.L. Landi, F. Sarnacchiaro, G. Facciolli, G. Lombardi, Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up. J. Clin. Endocrinol. Metab. 83(8), 2777\u20132780 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 1","key":"1438_CR33","first-page":"108","volume":"2","author":"MP Gillam","year":"2004","unstructured":"M.P. Gillam, H. Fideleff, H.R. Boquete, M.E. Molitch, Prolactin excess: treatment and toxicity. Pediatr. Endocrinol. Rev. 2(Suppl 1), 108\u2013114 (2004)","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"6","key":"1438_CR34","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00381-015-2679-5","volume":"31","author":"Y Liu","year":"2015","unstructured":"Y. Liu, Y. Yao, B. Xing, W. Lian, K. Deng, M. Feng, R. Wang, Prolactinomas in children under 14. Clinical presentation and long-term follow-up. Childs Nerv. Syst. 31(6), 909\u2013916 (2015). https:\/\/doi.org\/10.1007\/s00381-015-2679-5","journal-title":"Childs Nerv. Syst."},{"issue":"6","key":"1438_CR35","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1210\/endo.142.6.8219","volume":"142","author":"IF Palm","year":"2001","unstructured":"I.F. Palm, E.M. van der Beek, H.J. Swarts, J. van der Vliet, V.M. Wiegant, R.M. Buijs, A. Kalsbeek, Control of the estradiol-induced prolactin surge by the suprachiasmatic nucleus. Endocrinology 142(6), 2296\u20132302 (2001). https:\/\/doi.org\/10.1210\/endo.142.6.8219","journal-title":"Endocrinology"},{"issue":"5","key":"1438_CR36","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1210\/endo.131.5.1425416","volume":"131","author":"WJ DeVito","year":"1992","unstructured":"W.J. DeVito, C. Avakian, S. Stone, C.I. Ace, Estradiol increases prolactin synthesis and prolactin messenger ribonucleic acid in selected brain regions in the hypophysectomized female rat. Endocrinology 131(5), 2154\u20132160 (1992). https:\/\/doi.org\/10.1210\/endo.131.5.1425416","journal-title":"Endocrinology"},{"issue":"3","key":"1438_CR37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0303-7207(82)90084-3","volume":"25","author":"ME Lieberman","year":"1982","unstructured":"M.E. Lieberman, R. M., P. Claude, J. Gorski, Prolactin synthesis in primary cultures of pituitary cells: regulation by estradiol. Mol. Cell. Endocrinol. 25(3), 277\u2013294 (1982)","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4","key":"1438_CR38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000125919","volume":"54","author":"WJ DeVito","year":"1991","unstructured":"W.J. DeVito, S. Stone, C. Avakian, Stimulation of hypothalamic prolactin release by veratridine and angiotensin II in the female rat: effect of ovariectomy and estradiol administration. Neuroendocrinology 54(4), 391\u2013398 (1991)","journal-title":"Neuroendocrinology"},{"issue":"23","key":"1438_CR39","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1093\/emboj\/16.23.6926","volume":"16","author":"ND Horseman","year":"1997","unstructured":"N.D. Horseman, W. Zhao, E. Montecino-Rodriguez, M. Tanaka, K. Nakashima, S.J. Engle, F. Smith, E. Markoff, K. Dorshkind, Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 16(23), 6926\u20136935 (1997). https:\/\/doi.org\/10.1093\/emboj\/16.23.6926","journal-title":"EMBO J."},{"issue":"2","key":"1438_CR40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1006\/frne.2001.0212","volume":"22","author":"PA Kelly","year":"2001","unstructured":"P.A. Kelly, N. Binart, B. Lucas, B. Bouchard, V. Goffin, Implications of multiple phenotypes observed in prolactin receptor knockout mice. Front. Neuroendocrinol. 22(2), 140\u2013145 (2001). https:\/\/doi.org\/10.1006\/frne.2001.0212","journal-title":"Front. Neuroendocrinol."},{"issue":"1","key":"1438_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1006\/dbio.1999.9271","volume":"210","author":"C Brisken","year":"1999","unstructured":"C. Brisken, S. Kaur, T.E. Chavarria, N. Binart, R.L. Sutherland, R.A. Weinberg, P.A. Kelly, C.J. Ormandy, Prolactin controls mammary gland development via direct and indirect mechanisms. Dev. Biol. 210(1), 96\u2013106 (1999). https:\/\/doi.org\/10.1006\/dbio.1999.9271","journal-title":"Dev. Biol."},{"issue":"2","key":"1438_CR42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1101\/gad.11.2.167","volume":"11","author":"CJ Ormandy","year":"1997","unstructured":"C.J. Ormandy, A. Camus, J. Barra, D. Damotte, B. Lucas, H. Buteau, M. Edery, N. Brousse, C. Babinet, N. Binart, P.A. Kelly, Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11(2), 167\u2013178 (1997)","journal-title":"Genes Dev."},{"key":"1438_CR43","doi-asserted-by":"publisher","unstructured":"M.E. Molitch, Prolactin in human reproduction. 45\u201365.e11 (2014). https:\/\/doi.org\/10.1016\/b978-1-4557-2758-2.00003-2","DOI":"10.1016\/b978-1-4557-2758-2.00003-2"},{"issue":"4","key":"1438_CR44","first-page":"368","volume":"80","author":"T Douchi","year":"2001","unstructured":"T. Douchi, M. Nakae, S. Yamamoto, I. Iwamoto, T. Oki, Y. Nagata, A woman with isolated prolactin deficiency. Acta Obstet. Gynecol. Scand. 80(4), 368\u2013370 (2001)","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"5","key":"1438_CR45","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1471-0528.1997.tb11548.x","volume":"104","author":"AH Zargar","year":"1997","unstructured":"A.H. Zargar, S.R. Masoodi, B.A. Laway, N.A. Shah, M. Salahudin, Familial puerperal alactogenesis: possibility of a genetically transmitted isolated prolactin deficiency. Br. J. Obstet. Gynaecol. 104(5), 629\u2013631 (1997)","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"5","key":"1438_CR46","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0015-0282(16)55460-0","volume":"58","author":"RJ Falk","year":"1992","unstructured":"R.J. Falk, Isolated prolactin deficiency: a case report. Fertil. Steril. 58(5), 1060\u20131062 (1992)","journal-title":"Fertil. Steril."},{"issue":"2","key":"1438_CR47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/jcem-64-2-309","volume":"64","author":"A Kauppila","year":"1987","unstructured":"A. Kauppila, P. Chatelain, P. Kirkinen, S. Kivinen, A. Ruokonen, Isolated prolactin deficiency in a woman with puerperal alactogenesis. J. Clin. Endocrinol. Metab. 64(2), 309\u2013312 (1987). https:\/\/doi.org\/10.1210\/jcem-64-2-309","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"1438_CR48","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/j.1463-1326.2010.01304.x","volume":"12","author":"RI Holt","year":"2010","unstructured":"R.I. Holt, A.H. Barnett, C.J. Bailey, Bromocriptine: old drug, new formulation and new indication. Diabetes Obes. Metab. 12(12), 1048\u20131057 (2010). https:\/\/doi.org\/10.1111\/j.1463-1326.2010.01304.x","journal-title":"Diabetes Obes. Metab."},{"issue":"4","key":"1438_CR49","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1210\/jcem-66-4-868","volume":"66","author":"B Scoccia","year":"1988","unstructured":"B. Scoccia, A.B. Schneider, E.L. Marut, A. Scommegna, Pathological hyperprolactinemia suppresses hot flashes in menopausal women. J. Clin. Endocrinol. Metab. 66(4), 868\u2013871 (1988). https:\/\/doi.org\/10.1210\/jcem-66-4-868","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"1438_CR50","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2265.1976.tb01981.x","volume":"5","author":"MR Glass","year":"1976","unstructured":"M.R. Glass, R.W. Shaw, J.W. Williams, W.R. Butt, R. Logan-Edwards, D.R. London, The control of gonadotrophin release in women with hyperprolactinaemic amenorrhoea: effect of oestrogen and progesterone on the LH and FSH response to LHRH. Clin. Endocrinol. 5(5), 521\u2013530 (1976)","journal-title":"Clin. Endocrinol."},{"issue":"5468","key":"1438_CR51","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/250653a0","volume":"250","author":"KP McNatty","year":"1974","unstructured":"K.P. McNatty, R.S. Sawers, A.S. McNeilly, A possible role for prolactin in control of steroid secretion by the human Graafian follicle. Nature 250(5468), 653\u2013655 (1974)","journal-title":"Nature"},{"issue":"6","key":"1438_CR52","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1210\/jcem-54-6-1246","volume":"54","author":"R Demura","year":"1982","unstructured":"R. Demura, M. O., H. Demura, K. Shizume, H. Oouchi, Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17 beta-estradiol in the human ovary. J. Clin. Endocrinol. Metab. 54(6), 1246\u20131250 (1982)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"1438_CR53","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/jne.12223","volume":"26","author":"RS Brown","year":"2014","unstructured":"R.S. Brown, A.E. Herbison, D.R. Grattan, Prolactin regulation of kisspeptin neurones in the mouse brain and its role in the lactation-induced suppression of kisspeptin expression. J. Neuroendocrinol. 26(12), 898\u2013908 (2014). https:\/\/doi.org\/10.1111\/jne.12223","journal-title":"J. Neuroendocrinol."},{"key":"1438_CR54","doi-asserted-by":"publisher","unstructured":"M. Kotani, F. Katagiri, T. Hirai, J. Kagawa I. Tanaka, Plasma kisspeptin levels in lactational amenorrhea. Gynecol. Endocrinol. (2017). https:\/\/doi.org\/10.1080\/09513590.2017.1320380","DOI":"10.1080\/09513590.2017.1320380"},{"issue":"6","key":"1438_CR55","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.beem.2011.08.001","volume":"25","author":"D Unuane","year":"2011","unstructured":"D. Unuane, H. Tournaye, B. Velkeniers, K. Poppe, Endocrine disorders & female infertility. Best. Pract. Res. Clin. Endocrinol. Metab. 25(6), 861\u2013873 (2011). https:\/\/doi.org\/10.1016\/j.beem.2011.08.001","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"3","key":"1438_CR56","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0002-9378(81)90006-5","volume":"139","author":"JV Kredentser","year":"1981","unstructured":"J.V. Kredentser, C.F. Hoskins, J.Z. Scott, Hyperprolactinemia--a significant factor in female infertility. Am. J. Obstet. Gynecol. 139(3), 264\u2013267 (1981)","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"1438_CR57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0020-7292(85)90007-4","volume":"23","author":"L Bahamondes","year":"1985","unstructured":"L. Bahamondes, A. Faundes, M. Tambascia, M. Trevisan, J.N. Dachs, J.A. Pinotti, Menstrual pattern and ovarian function in women with hyperprolactinemia. Int. J. Gynaecol. Obstet. 23(1), 31\u201336 (1985)","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"3","key":"1438_CR58","first-page":"213","volume":"23","author":"D Muhlenstedt","year":"1978","unstructured":"D. Muhlenstedt, H.G. Bohnet, J.P. Hanker, H.P. Schneider, Short luteal phase and prolactin. Int. J. Fertil. 23(3), 213\u2013218 (1978)","journal-title":"Int. J. Fertil."},{"issue":"4","key":"1438_CR59","first-page":"651","volume":"78","author":"KE Huang","year":"1991","unstructured":"K.E. Huang, T.A. Bonfiglio, E.K. Muechler, Transient hyperprolactinemia in infertile women with luteal phase deficiency. Obstet. Gynecol. 78(4), 651\u2013655 (1991)","journal-title":"Obstet. Gynecol."},{"issue":"14","key":"1438_CR60","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJM199410063311403","volume":"331","author":"J Webster","year":"1994","unstructured":"J. Webster, G. Piscitelli, A. Polli, C.I. Ferrari, I. Ismail, M.F. Scanlon, A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline comparative study group. N. Engl. J. Med. 331(14), 904\u2013909 (1994). https:\/\/doi.org\/10.1056\/NEJM199410063311403","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"1438_CR61","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.beem.2011.05.011","volume":"25","author":"ME Molitch","year":"2011","unstructured":"M.E. Molitch, Prolactinoma in pregnancy. Best. Pract. Res. Clin. Endocrinol. Metab. 25(6), 885\u2013896 (2011). https:\/\/doi.org\/10.1016\/j.beem.2011.05.011","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"4","key":"1438_CR62","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11102-010-0243-6","volume":"13","author":"G Stalldecker","year":"2010","unstructured":"G. Stalldecker, M.S. Mallea-Gil, M. Guitelman, A. Alfieri, M.C. Ballarino, L. Boero, A. Chervin, K. Danilowicz, S. Diez, P. Fainstein-Day, N. Garcia-Basavilbaso, M. Glerean, V. Gollan, D. Katz, M.G. Loto, M. Manavela, A.S. Rogozinski, M. Servidio, N.M. Vitale, Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature. Pituitary 13(4), 345\u2013350 (2010). https:\/\/doi.org\/10.1007\/s11102-010-0243-6","journal-title":"Pituitary"},{"issue":"2","key":"1438_CR63","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","volume":"65","author":"FF Casanueva","year":"2006","unstructured":"F.F. Casanueva, M.E. Molitch, J.A. Schlechte, R. Abs, V. Bonert, M.D. Bronstein, T. Brue, P. Cappabianca, A. Colao, R. Fahlbusch, H. Fideleff, M. Hadani, P. Kelly, D. Kleinberg, E. Laws, J. Marek, M. Scanlon, L.G. Sobrinho, J.A. Wass, A. Giustina, Guidelines of the pituitary society for the diagnosis and management of prolactinomas. Clin. Endocrinol. 65(2), 265\u2013273 (2006). https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02562.x","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"1438_CR64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0002-9343(88)80346-2","volume":"85","author":"JG Gonzalez","year":"1988","unstructured":"J.G. Gonzalez, G. Elizondo, D. Saldivar, H. Nanez, L.E. Todd, J.Z. Villarreal, Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am. J. Med. 85(2), 217\u2013220 (1988)","journal-title":"Am. J. Med."},{"issue":"1","key":"1438_CR65","first-page":"64","volume":"39","author":"H Dinc","year":"1998","unstructured":"H. Dinc, F. Esen, A. Demirci, A. Sari, H. Resit Gumele, Pituitary dimensions and volume measurements in pregnancy and post partum. MR assessment. Acta Radiol. 39(1), 64\u201369 (1998)","journal-title":"Acta Radiol."},{"issue":"2","key":"1438_CR66","first-page":"183","volume":"19","author":"RA Ferriani","year":"1986","unstructured":"R.A. Ferriani, M.F. Silva-de-Sa, E.C. de-Lima-Filho, A comparative study of longitudinal and cross-sectional changes in plasma levels of prolactin and estriol during normal pregnancy. Braz. J. Med. Biol. Res. 19(2), 183\u2013188 (1986)","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"2","key":"1438_CR67","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1210\/jcem-48-2-288","volume":"48","author":"O Ylikorkala","year":"1979","unstructured":"O. Ylikorkala, S. Kivinen, M. Reinila, Serial prolactin and thyrotropin responses to thyrotropin-releasing hormone throughout normal human pregnancy. J. Clin. Endocrinol. Metab. 48(2), 288\u2013292 (1979). https:\/\/doi.org\/10.1210\/jcem-48-2-288","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 3","key":"1438_CR68","doi-asserted-by":"publisher","first-page":"S267","DOI":"10.4103\/2230-8210.84883","volume":"15","author":"SK Bajwa","year":"2011","unstructured":"S.K. Bajwa, S.J. Bajwa, P. Mohan, A. Singh, Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy. Indian J Endocrinol Metab 15, (Suppl 3), S267\u2013270 (2011). https:\/\/doi.org\/10.4103\/2230-8210.84883","journal-title":"Indian J Endocrinol Metab"},{"issue":"5","key":"1438_CR69","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/cen.12370","volume":"80","author":"ME Domingue","year":"2014","unstructured":"M.E. Domingue, F. Devuyst, O. Alexopoulou, B. Corvilain, D. Maiter, Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients. Clin. Endocrinol. 80(5), 642\u2013648 (2014). https:\/\/doi.org\/10.1111\/cen.12370","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"1438_CR70","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2265.2010.03808.x","volume":"73","author":"M Lebbe","year":"2010","unstructured":"M. Lebbe, C. Hubinont, P. Bernard, D. Maiter, Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women. Clin. Endocrinol. 73(2), 236\u2013242 (2010). https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03808.x","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"1438_CR71","first-page":"425","volume":"62","author":"WA Divers Jr","year":"1983","unstructured":"W.A. Divers Jr, S.S. Yen, Prolactin-producing microadenomas in pregnancy. Obstet. Gynecol. 62(4), 425\u2013429 (1983)","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"1438_CR72","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1530\/acta.0.1110452","volume":"111","author":"U Holmgren","year":"1986","unstructured":"U. Holmgren, G. Bergstrand, K. Hagenfeldt, S. Werner, Women with prolactinoma\u2014effect of pregnancy and lactation on serum prolactin and on tumour growth. Acta. Endocrinol. 111(4), 452\u2013459 (1986)","journal-title":"Acta. Endocrinol."},{"issue":"2","key":"1438_CR73","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"S. Melmed, F.F. Casanueva, A.R. Hoffman, D.L. Kleinberg, V.M. Montori, J.A. Schlechte, J.A. Wass, S. Endocrine, Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(2), 273\u2013288 (2011). https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"1438_CR74","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/BF03348017","volume":"20","author":"E Ciccarelli","year":"1997","unstructured":"E. Ciccarelli, S. Grottoli, P. Razzore, D. Gaia, A. Bertagna, S. Cirillo, T. Cammarota, M. Camanni, F. Camanni, Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy. J. Endocrinol. Invest. 20(9), 547\u2013551 (1997). https:\/\/doi.org\/10.1007\/BF03348017","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"1438_CR75","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0889-8545(05)70012-7","volume":"25","author":"R Boulay","year":"1998","unstructured":"R. Boulay, E. Podczaski, Ovarian cancer complicating pregnancy. Obstet. Gynecol. Clin. N. Am. 25(2), 385\u2013399 (1998)","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"issue":"5","key":"1438_CR76","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1530\/EJE-14-0848","volume":"172","author":"ME Molitch","year":"2015","unstructured":"M.E. Molitch, Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma. Eur. J. Endocrinol. 172(5), R205\u2013213 (2015). https:\/\/doi.org\/10.1530\/EJE-14-0848","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"1438_CR77","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijgo.2007.04.027","volume":"99","author":"M Laloi-Michelin","year":"2007","unstructured":"M. Laloi-Michelin, N. Ciraru-Vigneron, T. Meas, Cabergoline treatment of pregnant women with macroprolactinomas. Int. J. Gynaecol. Obstet. 99(1), 61\u201362 (2007). https:\/\/doi.org\/10.1016\/j.ijgo.2007.04.027","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"3","key":"1438_CR78","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF03350411","volume":"2","author":"WD Lehmann","year":"1979","unstructured":"W.D. Lehmann, K. Musch, A.S. Wolf, Influence of bromocriptine on plasma levels of prolactin and steroid hormones in the 20th week of pregnancy. J. Endocrinol. Invest. 2(3), 251\u2013255 (1979). https:\/\/doi.org\/10.1007\/BF03350411","journal-title":"J. Endocrinol. Invest."},{"issue":"5","key":"1438_CR79","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1365-2265.2008.03425.x","volume":"70","author":"A Banerjee","year":"2009","unstructured":"A. Banerjee, K. Wynne, T. Tan, E.C. Hatfield, N.M. Martin, C. Williamson, K. Meeran, High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy. Clin. Endocrinol. 70(5), 812\u2013813 (2009). https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03425.x","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"1438_CR80","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000180100","volume":"22","author":"JP Raymond","year":"1985","unstructured":"J.P. Raymond, E. Goldstein, P. Konopka, M.F. Leleu, R.E. Merceron, Y. Loria, Follow-up of children born of bromocriptine-treated mothers. Horm. Res. 22(3), 239\u2013246 (1985)","journal-title":"Horm. Res."},{"issue":"6","key":"1438_CR81","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1210\/jc.2009-2605","volume":"95","author":"M Ono","year":"2010","unstructured":"M. Ono, N. Miki, K. Amano, T. Kawamata, T. Seki, R. Makino, K. Takano, S. Izumi, Y. Okada, T. Hori, Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J. Clin. Endocrinol. Metab. 95(6), 2672\u20132679 (2010). https:\/\/doi.org\/10.1210\/jc.2009-2605","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"1438_CR82","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0015-0282(16)45806-1","volume":"36","author":"ES Canales","year":"1981","unstructured":"E.S. Canales, I.C. Garcia, J.E. Ruiz, A. Zarate, Bromocriptine as prophylactic therapy in prolactinoma during pregnancy. Fertil. Steril. 36(4), 524\u2013526 (1981)","journal-title":"Fertil. Steril."},{"issue":"8","key":"1438_CR83","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0002-9378(83)90968-7","volume":"146","author":"P Konopka","year":"1983","unstructured":"P. Konopka, J.P. Raymond, R.E. Merceron, J. Seneze, Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am. J. Obstet. Gynecol. 146(8), 935\u2013938 (1983)","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"1438_CR84","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0015-0282(16)47888-X","volume":"41","author":"V Ruiz-Velasco","year":"1984","unstructured":"V. Ruiz-Velasco, G. Tolis, Pregnancy in hyperprolactinemic women. Fertil. Steril. 41(6), 793\u2013805 (1984)","journal-title":"Fertil. Steril."},{"issue":"2","key":"1438_CR85","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1064-9689(21)00346-9","volume":"2","author":"E Kanal","year":"1994","unstructured":"E. Kanal, Pregnancy and the safety of magnetic resonance imaging. Magn. Reson. Imaging Clin. N. Am. 2(2), 309\u2013317 (1994)","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"issue":"3","key":"1438_CR86","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/jmri.24011","volume":"37","author":"E Kanal","year":"2013","unstructured":"Expert Panel on, M.R.S., E. Kanal, A.J. Barkovich, C. Bell, J.P. Borgstede, W.G. Bradley Jr., J.W. Froelich, J.R. Gimbel, J.W. Gosbee, E. Kuhni-Kaminski, P.A. Larson, J.W. Lester Jr., J. Nyenhuis, D.J. Schaefer, E.A. Sebek, J. Weinreb, B.L. Wilkoff, T.O. Woods, L. Lucey, D. Hernandez, ACR guidance document on MR safe practices: 2013. J. Magn. Reson. Imaging 37(3), 501\u2013530 (2013). https:\/\/doi.org\/10.1002\/jmri.24011","journal-title":"J. Magn. Reson. Imaging"},{"issue":"3","key":"1438_CR87","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2362.2010.02399.x","volume":"41","author":"WA Mann","year":"2011","unstructured":"W.A. Mann, Treatment for prolactinomas and hyperprolactinaemia: a lifetime approach. Eur. J. Clin. Invest. 41(3), 334\u2013342 (2011). https:\/\/doi.org\/10.1111\/j.1365-2362.2010.02399.x","journal-title":"Eur. J. Clin. Invest."},{"issue":"3","key":"1438_CR88","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s12020-014-0281-3","volume":"47","author":"R Salvatori","year":"2014","unstructured":"R. Salvatori, Surgical treatment of microprolactinomas: pros. Endocrine 47(3), 725\u2013729 (2014). https:\/\/doi.org\/10.1007\/s12020-014-0281-3","journal-title":"Endocrine"},{"key":"1438_CR89","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-14-0043","volume":"2014","author":"AR Hayes","year":"2014","unstructured":"A.R. Hayes, A.J. O\u2019Sullivan, M.A. Davies, A case of pituitary apoplexy in pregnancy. Endocrinol. Diabetes Metab. Case Rep. 2014, 140043 (2014). https:\/\/doi.org\/10.1530\/EDM-14-0043","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"issue":"1","key":"1438_CR90","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9378(72)90446-2","volume":"113","author":"JE Tyson","year":"1972","unstructured":"J.E. Tyson, P. Hwang, H. Guyda, H.G. Friesen, Studies of prolactin secretion in human pregnancy. Am. J. Obstet. Gynecol. 113(1), 14\u201320 (1972)","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"1438_CR91","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1113\/expphysiol.1996.sp003985","volume":"81","author":"DB Cox","year":"1996","unstructured":"D.B. Cox, R.A. Owens, P.E. Hartmann, Blood and milk prolactin and the rate of milk synthesis in women. Exp. Physiol. 81(6), 1007\u20131020 (1996)","journal-title":"Exp. Physiol."},{"issue":"1","key":"1438_CR92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07435809609030495","volume":"22","author":"JF Stallings","year":"1996","unstructured":"J.F. Stallings, C.M. Worthman, C. Panter-Brick, R.J. Coates, Prolactin response to suckling and maintenance of postpartum amenorrhea among intensively breastfeeding Nepali women. Endocr. Res. 22(1), 1\u201328 (1996)","journal-title":"Endocr. Res."},{"issue":"3","key":"1438_CR93","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9378(15)31297-7","volume":"116","author":"JE Tyson","year":"1973","unstructured":"J.E. Tyson, H.G. Friesen, Factors influencing the secretion of human prolactin and growth hormone in menstrual and gestational women. Am. J. Obstet. Gynecol. 116(3), 377\u2013387 (1973)","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"1438_CR94","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM198701293160501","volume":"316","author":"VC Musey","year":"1987","unstructured":"V.C. Musey, D.C. Collins, P.I. Musey, D. Martino-Saltzman, J.R. Preedy, Long-term effect of a first pregnancy on the secretion of prolactin. N. Engl. J. Med. 316(5), 229\u2013234 (1987). https:\/\/doi.org\/10.1056\/NEJM198701293160501","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"1438_CR95","first-page":"758","volume":"37","author":"O Narita","year":"1985","unstructured":"O. Narita, T. Kimura, N. Suganuma, M. Osawa, S. Mizutani, T. Masahashi, M. Asai, Y. Tomoda, Relationship between maternal prolactin levels during pregnancy and lactation in women with pituitary adenoma. Nihon Sanka Fujinka Gakkai Zasshi 37(5), 758\u2013762 (1985)","journal-title":"Nihon Sanka Fujinka Gakkai Zasshi"},{"issue":"5","key":"1438_CR96","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0015-0282(16)59182-1","volume":"47","author":"H Ikegami","year":"1987","unstructured":"H. Ikegami, T. Aono, K. Koizumi, K. Koike, H. Fukui, O. Tanizawa, Relationship between the methods of treatment for prolactinomas and the puerperal lactation. Fertil. Steril. 47(5), 867\u2013869 (1987)","journal-title":"Fertil. Steril."},{"issue":"1","key":"1438_CR97","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1210\/jc.2012-3039","volume":"98","author":"RS Auriemma","year":"2013","unstructured":"R.S. Auriemma, Y. Perone, A. Di Sarno, L.F. Grasso, E. Guerra, M. Gasperi, R. Pivonello, A. Colao, Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation. J. Clin. Endocrinol. Metab. 98(1), 372\u2013379 (2013). https:\/\/doi.org\/10.1210\/jc.2012-3039","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1438_CR98","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1530\/acta.0.0920407","volume":"92","author":"A Zarate","year":"1979","unstructured":"A. Zarate, E.S. Canales, M. Alger, G. Forsbach, The effect of pregnancy and lactation on pituitary prolactin-secreting tumours. Acta Endocrinol. 92(3), 407\u2013412 (1979)","journal-title":"Acta Endocrinol."},{"issue":"3","key":"1438_CR99","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11102-010-0217-8","volume":"13","author":"L Vilar","year":"2010","unstructured":"L. Vilar, L.A. Naves, L.A. Casulari, M.F. Azevedo, J.L. Albuquerque, F.M. Serfaty, F.R. Pinho Barbosa, A.R. de Oliveira Jr., R.M. Montenegro, R.M. Montenegro Jr., A.J. Ramos, M. Dos Santos Faria, N.R. Musolino, M.R. Gadelha, C.L. Boguszewski, M.D. Bronstein, Management of prolactinomas in Brazil: an electronic survey. Pituitary 13(3), 199\u2013206 (2010). https:\/\/doi.org\/10.1007\/s11102-010-0217-8","journal-title":"Pituitary"},{"issue":"3","key":"1438_CR100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/acta.0.1000337","volume":"100","author":"HK Rjosk","year":"1982","unstructured":"H.K. Rjosk, R. Fahlbusch, K. von Werder, Influence of pregnancies on prolactinomas. Acta Endocrinol. 100(3), 337\u2013346 (1982)","journal-title":"Acta Endocrinol."},{"issue":"3","key":"1438_CR101","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0028-2243(92)90094-F","volume":"44","author":"PG Crosignani","year":"1992","unstructured":"P.G. Crosignani, A.M. Mattei, V. Severini, V. Cavioni, P. Maggioni, G. Testa, Long-term effects of time, medical treatment and pregnancy in 176 hyperprolactinemic women. Eur. J. Obstet. Gynecol. Reprod. Biol. 44(3), 175\u2013180 (1992)","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"3","key":"1438_CR102","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2265.1996.00824.x","volume":"45","author":"WJ Jeffcoate","year":"1996","unstructured":"W.J. Jeffcoate, N. Pound, N.D. Sturrock, J. Lambourne, Long-term follow-up of patients with hyperprolactinaemia. Clin. Endocrinol. 45(3), 299\u2013303 (1996)","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"1438_CR103","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1677\/erc.0.0080287","volume":"8","author":"BM Arafah","year":"2001","unstructured":"B.M. Arafah, M.P. Nasrallah, Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr. Relat. Cancer 8(4), 287\u2013305 (2001)","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"1438_CR104","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0090-3019(01)00407-4","volume":"55","author":"H Nishioka","year":"2001","unstructured":"H. Nishioka, H. Ito, J. Haraoka, A. Hirano, Growth potential of female prolactinomas. Surg. Neurol. 55(4), 213\u2013217 (2001)","journal-title":"Surg. Neurol."},{"issue":"1","key":"1438_CR105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.7326\/0003-4819-100-1-115","volume":"100","author":"MC Koppelman","year":"1984","unstructured":"M.C. Koppelman, M.J. Jaffe, K.G. Rieth, R.C. Caruso, D.L. Loriaux, Hyperprolactinemia, amenorrhea, and galactorrhea. A retrospective assessment of twenty-five cases. Ann. Intern. Med. 100(1), 115\u2013121 (1984)","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"1438_CR106","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0002-9378(81)90553-6","volume":"139","author":"CM March","year":"1981","unstructured":"C.M. March, O.A. Kletzky, V. Davajan, J. Teal, M. Weiss, M.L. Apuzzo, R.P. Marrs, D.R. Mishell Jr., Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas. Am. J. Obstet. Gynecol. 139(7), 835\u2013844 (1981)","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"1438_CR107","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1210\/jcem-68-2-412","volume":"68","author":"J Schlechte","year":"1989","unstructured":"J. Schlechte, K. Dolan, B. Sherman, F. Chapler, A. Luciano, The natural history of untreated hyperprolactinemia: a prospective analysis. J. Clin. Endocrinol. Metab. 68(2), 412\u2013418 (1989). https:\/\/doi.org\/10.1210\/jcem-68-2-412","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1438_CR108","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0015-0282(16)59292-9","volume":"48","author":"DA Sisam","year":"1987","unstructured":"D.A. Sisam, J.P. Sheehan, L.R. Sheeler, The natural history of untreated microprolactinomas. Fertil. Steril. 48(1), 67\u201371 (1987)","journal-title":"Fertil. Steril."},{"key":"1438_CR109","first-page":"443","volume-title":"The Pituitary","author":"M Molitch","year":"1995","unstructured":"M. Molitch, in Prolactinomas, ed. by S. Melmed. The Pituitary(Blackwell Science, Cambridge, 1995), pp. 443\u2013477"},{"issue":"2","key":"1438_CR110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1227\/00006123-198302000-00008","volume":"12","author":"MH Weiss","year":"1983","unstructured":"M.H. Weiss, J. Teal, P. Gott, R. Wycoff, R. Yadley, M.L. Apuzzo, S.L. Giannotta, O. Kletzky, C. March, Natural history of microprolactinomas: six-year follow-up. Neurosurgery 12(2), 180\u2013183 (1983)","journal-title":"Neurosurgery"},{"key":"1438_CR111","first-page":"117","volume":"44","author":"ME Molitch","year":"1999","unstructured":"M.E. Molitch, Diagnosis and treatment of prolactinomas. Adv. Intern. Med. 44, 117\u2013153 (1999)","journal-title":"Adv. Intern. Med."},{"key":"1438_CR112","doi-asserted-by":"crossref","unstructured":"K.A. Katznelson L, in Prolactinomas, ed. by A.A. Endocrine Neoplasms. (Kluver Academic, Boston, 1997), pp. 41\u201355","DOI":"10.1007\/978-1-4615-6355-6_3"},{"key":"1438_CR113","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0090-3019(01)00407-4","volume":"55","author":"H Nishioka","year":"2001","unstructured":"H. Nishioka, H. I., J. Haraoka, A. Hirano, Growth potential of female prolactinomas. Surg. Neurol. 55, 213\u2013217 (2001)","journal-title":"Surg. Neurol."},{"issue":"1","key":"1438_CR114","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1365-2265.2005.02293.x","volume":"63","author":"M Biswas","year":"2005","unstructured":"M. Biswas, J. Smith, D. Jadon, P. McEwan, D.A. Rees, L.M. Evans, M.F. Scanlon, J.S. Davies, Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas. Clin. Endocrinol. 63(1), 26\u201331 (2005). https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02293.x","journal-title":"Clin. Endocrinol."},{"issue":"7","key":"1438_CR115","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1210\/jc.2008-2103","volume":"94","author":"J Kharlip","year":"2009","unstructured":"J. Kharlip, R. Salvatori, G. Yenokyan, G.S. Wand, Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy. J. Clin. Endocrinol. Metab. 94(7), 2428\u20132436 (2009). https:\/\/doi.org\/10.1210\/jc.2008-2103","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"21","key":"1438_CR116","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1056\/NEJMoa022657","volume":"349","author":"A Colao","year":"2003","unstructured":"A. Colao, A. Di Sarno, P. Cappabianca, C. Di Somma, R. Pivonello, G. Lombardi, Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N. Engl. J. Med. 349(21), 2023\u20132033 (2003). https:\/\/doi.org\/10.1056\/NEJMoa022657","journal-title":"N. Engl. J. Med."},{"key":"1438_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-015-0006-4","volume":"1","author":"A Tirosh","year":"2015","unstructured":"A. Tirosh, I. Shimon, Management of macroprolactinomas. Clin. Diabetes Endocrinol. 1, 5 (2015). https:\/\/doi.org\/10.1186\/s40842-015-0006-4","journal-title":"Clin. Diabetes Endocrinol."},{"issue":"12","key":"1438_CR118","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1210\/jc.2007-2758","volume":"93","author":"M Ono","year":"2008","unstructured":"M. Ono, N. Miki, T. Kawamata, R. Makino, K. Amano, T. Seki, O. Kubo, T. Hori, K. Takano, Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients. J. Clin. Endocrinol. Metab. 93(12), 4721\u20134727 (2008). https:\/\/doi.org\/10.1210\/jc.2007-2758","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"1438_CR119","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1210\/jc.2002-020426","volume":"87","author":"MP Gillam","year":"2002","unstructured":"M.P. Gillam, S. Middler, D.J. Freed, M.E. Molitch, The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. J. Clin. Endocrinol. Metab. 87(10), 4447\u20134451 (2002). https:\/\/doi.org\/10.1210\/jc.2002-020426","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1438_CR120","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2265.2009.03608.x","volume":"72","author":"LB Nachtigall","year":"2010","unstructured":"L.B. Nachtigall, E. Valassi, J. Lo, D. McCarty, J. Passeri, B.M. Biller, K.K. Miller, A. Utz, S. Grinspoon, E.A. Lawson, A. Klibanski, Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study. Clin. Endocrinol. 72(1), 53\u201358 (2010). https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03608.x","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"1438_CR121","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2265.2008.03458.x","volume":"70","author":"N Herring","year":"2009","unstructured":"N. Herring, C. Szmigielski, H. Becher, N. Karavitaki, J.A. Wass, Valvular heart disease and the use of cabergoline for the treatment of prolactinoma. Clin. Endocrinol. 70(1), 104\u2013108 (2009). https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03458.x","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"1438_CR122","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/cen.12375","volume":"80","author":"I Bancos","year":"2014","unstructured":"I. Bancos, M.R. Nannenga, J.M. Bostwick, M.H. Silber, D. Erickson, T.B. Nippoldt, Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study. Clin. Endocrinol. 80(6), 863\u2013868 (2014). https:\/\/doi.org\/10.1111\/cen.12375","journal-title":"Clin. Endocrinol."},{"issue":"12","key":"1438_CR123","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","volume":"174","author":"TJ Moore","year":"2014","unstructured":"T.J. Moore, J. Glenmullen, D.R. Mattison, Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern. Med. 174(12), 1930\u20131933 (2014). https:\/\/doi.org\/10.1001\/jamainternmed.2014.5262","journal-title":"JAMA Intern. Med."},{"issue":"2","key":"1438_CR124","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s12020-016-1088-1","volume":"55","author":"SM Sousa De","year":"2017","unstructured":"S.M. De Sousa, I.M. Chapman, H. Falhammar, D.J. Torpy, Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists. Endocrine 55(2), 618\u2013624 (2017). https:\/\/doi.org\/10.1007\/s12020-016-1088-1","journal-title":"Endocrine"},{"issue":"3-4","key":"1438_CR125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/00207458708987147","volume":"37","author":"R Sandyk","year":"1987","unstructured":"R. Sandyk, M. Bergsneider, R.P. Iacono, Acute psychosis in a woman with a prolactinoma. Int. J. Neurosci. 37(3-4), 187\u2013190 (1987)","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"1438_CR126","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ecl.2014.10.013","volume":"44","author":"I Crespo","year":"2015","unstructured":"I. Crespo, E. Valassi, A. Santos, S.M. Webb, Health-related quality of life in pituitary diseases. Endocrinol. Metab. Clin. N. Am. 44(1), 161\u2013170 (2015). https:\/\/doi.org\/10.1016\/j.ecl.2014.10.013","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"2","key":"1438_CR127","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/B:PITU.0000004798.27230.ed","volume":"6","author":"MD Johnson","year":"2003","unstructured":"M.D. Johnson, C.J. Woodburn, M.L. Vance, Quality of life in patients with a pituitary adenoma. Pituitary 6(2), 81\u201387 (2003)","journal-title":"Pituitary"},{"issue":"3","key":"1438_CR128","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11102-008-0091-9","volume":"11","author":"E Cesar de Oliveira Naliato","year":"2008","unstructured":"E. Cesar de Oliveira Naliato, A.H. Dutra Violante, D. Caldas, A. Lamounier Filho, C. Rezende Loureiro, R. Fontes, Y. Schrank, R. Gomes de Souza, M. Vaisman, E. Guerra, A. Sebastian, A. Colao, Quality of life in women with microprolactinoma treated with dopamine agonists. Pituitary 11(3), 247\u2013254 (2008). https:\/\/doi.org\/10.1007\/s11102-008-0091-9","journal-title":"Pituitary"},{"key":"1438_CR129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1530\/EJE-07-0259","volume":"157","author":"M Kars","year":"2007","unstructured":"M. Kars, A. V. D. K., C.S. Onstein, Quality of life is decreased in female patients treated for microprolactinoma. Eur. J. Endocrinol. 157, 133\u2013139 (2007)","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"1438_CR130","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000335996","volume":"96","author":"AP Athanasoulia","year":"2012","unstructured":"A.P. Athanasoulia, M. Ising, H. Pfister, C.S. Mantzoros, G.K. Stalla, C. Sievers, Distinct dopaminergic personality patterns in patients with prolactinomas: a comparison with nonfunctioning pituitary adenoma patients and age- and gender-matched controls. Neuroendocrinology 96(3), 204\u2013211 (2012). https:\/\/doi.org\/10.1159\/000335996","journal-title":"Neuroendocrinology"},{"issue":"5","key":"1438_CR131","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1365-2265.2008.03288.x","volume":"69","author":"AA Klaauw van der","year":"2008","unstructured":"A.A. van der Klaauw, M. Kars, N.R. Biermasz, F. Roelfsema, O.M. Dekkers, E.P. Corssmit, M.O. van Aken, B. Havekes, A.M. Pereira, H. Pijl, J.W. Smit, J.A. Romijn, Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin. Endocrinol. 69(5), 775\u2013784 (2008). https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03288.x","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"1438_CR132","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1530\/EJE-07-0259","volume":"157","author":"M Kars","year":"2007","unstructured":"M. Kars, A.A. van der Klaauw, C.S. Onstein, A.M. Pereira, J.A. Romijn, Quality of life is decreased in female patients treated for microprolactinoma. Eur. J. Endocrinol. 157(2), 133\u2013139 (2007). https:\/\/doi.org\/10.1530\/EJE-07-0259","journal-title":"Eur. J. Endocrinol."},{"issue":"26","key":"1438_CR133","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJM198012253032605","volume":"303","author":"A Klibanski","year":"1980","unstructured":"A. Klibanski, R.M. Neer, I.Z. Beitins, E.C. Ridgway, N.T. Zervas, J.W. McArthur, Decreased bone density in hyperprolactinemic women. N. Engl. J. Med. 303(26), 1511\u20131514 (1980). https:\/\/doi.org\/10.1056\/NEJM198012253032605","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"1438_CR134","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1210\/jcem-67-1-124","volume":"67","author":"A Klibanski","year":"1988","unstructured":"A. Klibanski, B.M. Biller, D.I. Rosenthal, D.A. Schoenfeld, V. Saxe, Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J. Clin. Endocrinol. Metab. 67(1), 124\u2013130 (1988). https:\/\/doi.org\/10.1210\/jcem-67-1-124","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1438_CR135","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1210\/jcem.75.3.1517357","volume":"75","author":"J Schlechte","year":"1992","unstructured":"J. Schlechte, L. Walkner, M. Kathol, A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia. J. Clin. Endocrinol. Metab. 75(3), 698\u2013703 (1992). https:\/\/doi.org\/10.1210\/jcem.75.3.1517357","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1438_CR136","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM197810192991602","volume":"299","author":"JN Carter","year":"1978","unstructured":"J.N. Carter, J. T, G. Tolis, S.V. Vliet, C. Faiman, H.G. Friesen, Prolactin-secreting tumors and hypogonadism in 22 men. N. Engl. J. Med. 299, 847\u2013852 (1978)","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"1438_CR137","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/jcb.22161","volume":"107","author":"D Seriwatanachai","year":"2009","unstructured":"D. Seriwatanachai, N. Krishnamra, J.P. van Leeuwen, Evidence for direct effects of prolactin on human osteoblasts: Inhibition of cell growth and mineralization. J. Cell. Biochem. 107(4), 677\u2013685 (2009). https:\/\/doi.org\/10.1002\/jcb.22161","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"1438_CR138","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.bone.2007.11.008","volume":"42","author":"D Seriwatanachai","year":"2008","unstructured":"D. Seriwatanachai, K. Thongchote, N. Charoenphandhu, J. Pandaranandaka, K. Tudpor, J. Teerapornpuntakit, T. Suthiphongchai, N. Krishnamra, Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand\/osteoprotegerin ratio. Bone 42(3), 535\u2013546 (2008). https:\/\/doi.org\/10.1016\/j.bone.2007.11.008","journal-title":"Bone"},{"issue":"6","key":"1438_CR139","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1210\/jcem.84.6.5688","volume":"84","author":"KK Miller","year":"1999","unstructured":"K.K. Miller, A. Klibanski, Clinical review 106: Amenorrheic bone loss. J. Clin. Endocrinol. Metab. 84(6), 1775\u20131783 (1999). https:\/\/doi.org\/10.1210\/jcem.84.6.5688","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"1438_CR140","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3109\/09513590.2012.683080","volume":"28","author":"Y Zhao","year":"2012","unstructured":"Y. Zhao, X. Gan, P. Luo, Q. He, Q. Guo, L. Zhang, X. Zhang, X. Zhang, Z. Fei, The risk of osteopenia in premenopausal women with various sellar tumors. Gynecol. Endocrinol. 28(12), 945\u2013948 (2012). https:\/\/doi.org\/10.3109\/09513590.2012.683080","journal-title":"Gynecol. Endocrinol."},{"issue":"3","key":"1438_CR141","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1210\/jcem.83.3.4674","volume":"83","author":"C Somma Di","year":"1998","unstructured":"C. Di Somma, A. Colao, A. Di Sarno, M. Klain, M.L. Landi, G. Facciolli, R. Pivonello, N. Panza, M. Salvatore, G. Lombardi, Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. J. Clin. Endocrinol. Metab. 83(3), 807\u2013813 (1998). https:\/\/doi.org\/10.1210\/jcem.83.3.4674","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1438_CR142","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.0300-0664.2001.01464.x","volume":"56","author":"P Vestergaard","year":"2002","unstructured":"P. Vestergaard, J. J., C. Hagen et al., Fracture risk is increased in patients with GH deficiency or untreated prolactinomas\u2014a case\u2013control study. Clin. Endocrinol. 56, 159\u2013167 (2002)","journal-title":"Clin. Endocrinol."},{"issue":"9","key":"1438_CR143","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1056\/NEJM198608283150903","volume":"315","author":"A Klibanski","year":"1986","unstructured":"A. Klibanski, S.L. Greenspan, Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N. Engl. J. Med. 315(9), 542\u2013546 (1986). https:\/\/doi.org\/10.1056\/NEJM198608283150903","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"1438_CR144","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1210\/jcem-64-5-1021","volume":"64","author":"J Schlechte","year":"1987","unstructured":"J. Schlechte, G. el-Khoury, M. Kathol, L. Walkner, Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea. J. Clin. Endocrinol. Metab. 64(5), 1021\u20131026 (1987). https:\/\/doi.org\/10.1210\/jcem-64-5-1021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"1438_CR145","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/09513590500279717","volume":"21","author":"DD Abech","year":"2005","unstructured":"D.D. Abech, H.B. Moratelli, S.C. Leite, M.C. Oliveira, Effects of estrogen replacement therapy on pituitary size, prolactin and thyroid-stimulating hormone concentrations in menopausal women. Gynecol. Endocrinol. 21(4), 223\u2013226 (2005). https:\/\/doi.org\/10.1080\/09513590500279717","journal-title":"Gynecol. Endocrinol."},{"issue":"3","key":"1438_CR146","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s12020-013-9931-0","volume":"44","author":"A Atmaca","year":"2013","unstructured":"A. Atmaca, B. Bilgici, G.C. Ecemis, O.K. Tuncel, Evaluation of body weight, insulin resistance, leptin and adiponectin levels in premenopausal women with hyperprolactinemia. Endocrine 44(3), 756\u2013761 (2013). https:\/\/doi.org\/10.1007\/s12020-013-9931-0","journal-title":"Endocrine"},{"issue":"3","key":"1438_CR147","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/bcpt.12307","volume":"116","author":"R Krysiak","year":"2015","unstructured":"R. Krysiak, B. Okopien, Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels. Basic Clin. Pharmacol. Toxicol. 116(3), 251\u2013256 (2015). https:\/\/doi.org\/10.1111\/bcpt.12307","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"15\u201316","key":"1438_CR148","first-page":"254","volume":"136","author":"C Schmid","year":"2006","unstructured":"C. Schmid, D.L. Goede, R.S. Hauser, M. Brandle, Increased prevalence of high body mass index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma. Swiss Med. Wkly 136(15\u201316), 254\u2013258 (2006). doi:2006\/15\/smw-10955","journal-title":"Swiss Med. Wkly"},{"issue":"5","key":"1438_CR149","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2265.1998.00403.x","volume":"48","author":"Y Greenman","year":"1998","unstructured":"Y. Greenman, K. Tordjman, N. Stern, Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. Clin. Endocrinol. 48(5), 547\u2013553 (1998)","journal-title":"Clin. Endocrinol."},{"key":"1438_CR150","first-page":"254","volume":"136","author":"C Schmid","year":"2006","unstructured":"C. Schmid, D. G., R.S. Hauser, M. Brandle, Increased prevalence of high body mass index in patients presenting with pituitary tumors: severe obesity in patients with macroprolactinoma. Swiss. Med. Wkly 136, 254\u2013258 (2006)","journal-title":"Swiss. Med. Wkly"},{"issue":"1","key":"1438_CR151","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1530\/eje.0.1470077","volume":"147","author":"M Doknic","year":"2002","unstructured":"M. Doknic, S. Pekic, M. Zarkovic, M. Medic-Stojanoska, C. Dieguez, F. Casanueva, V. Popovic, Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. Eur. J. Endocrinol. 147(1), 77\u201384 (2002)","journal-title":"Eur. J. Endocrinol."},{"issue":"9253","key":"1438_CR152","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0140-6736(00)03643-6","volume":"357","author":"GJ Wang","year":"2001","unstructured":"G.J. Wang, N.D. Volkow, J. Logan, N.R. Pappas, C.T. Wong, W. Zhu, N. Netusil, J.S. Fowler, Brain dopamine and obesity. Lancet 357(9253), 354\u2013357 (2001)","journal-title":"Lancet"},{"issue":"4","key":"1438_CR153","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1365-2265.2009.03752.x","volume":"73","author":"C Erem","year":"2010","unstructured":"C. Erem, M. Kocak, I. Nuhoglu, M. Yilmaz, O. Ucuncu, Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma. Clin. Endocrinol. 73(4), 502\u2013507 (2010). https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03752.x","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"1438_CR154","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12020-012-9857-y","volume":"44","author":"SS Inancli","year":"2013","unstructured":"S.S. Inancli, A. Usluogullari, Y. Ustu, S. Caner, A.A. Tam, R. Ersoy, B. Cakir, Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma. Endocrine 44(1), 193\u2013199 (2013). https:\/\/doi.org\/10.1007\/s12020-012-9857-y","journal-title":"Endocrine"},{"issue":"3","key":"1438_CR155","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11102-013-0495-z","volume":"17","author":"XB Jiang","year":"2014","unstructured":"X.B. Jiang, C. L., D.S. He, Z.G. Mao, D.H. Liu, X. Fan, B. Hu, Y.H. Zhu, H.J. Wang, Increased carotid intima media thickness is associated with prolactin levels in subjects with untreated prolactinoma: a pilot study. Pituitary 17(3), 232\u2013239 (2014)","journal-title":"Pituitary"},{"issue":"4","key":"1438_CR156","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/BF03345182","volume":"26","author":"A Tuzcu","year":"2003","unstructured":"A. Tuzcu, M. Bahceci, M. Dursun, C. Turgut, S. Bahceci, Insulin sensitivity and hyperprolactinemia. J. Endocrinol. Invest. 26(4), 341\u2013346 (2003). https:\/\/doi.org\/10.1007\/BF03345182","journal-title":"J. Endocrinol. Invest."},{"issue":"4","key":"1438_CR157","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1365-2265.2006.02469.x","volume":"64","author":"O Serri","year":"2006","unstructured":"O. Serri, L. Li, J.C. Mamputu, M.C. Beauchamp, F. Maingrette, G. Renier, The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clin. Endocrinol. 64(4), 366\u2013370 (2006). https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02469.x","journal-title":"Clin. Endocrinol."},{"key":"1438_CR158","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.bbrc.2005.04.026","volume":"331","author":"L Nilsson","year":"2005","unstructured":"L. Nilsson, R. B., M. Bohlooly-Y, M. Bramnert, E. Egecioglu, J. Kindblom, P.A. Kelly, J.J. Kopchick, C.J. Ormandy, C. Ling, H. Billig, Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem. Biophys. Res. Commun. 331, 1120\u20131126 (2005)","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"1438_CR159","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11102-010-0277-9","volume":"14","author":"K Berinder","year":"2011","unstructured":"K. Berinder, T. Nystrom, C. Hoybye, K. Hall, A.L. Hulting, Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy. Pituitary 14(3), 199\u2013207 (2011). https:\/\/doi.org\/10.1007\/s11102-010-0277-9","journal-title":"Pituitary"},{"issue":"8","key":"1438_CR160","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2337\/diacare.23.8.1154","volume":"23","author":"H Pijl","year":"2000","unstructured":"H. Pijl, S. Ohashi, M. Matsuda, Y. Miyazaki, A. Mahankali, V. Kumar, R. Pipek, P. Iozzo, J.L. Lancaster, A.H. Cincotta, R.A. DeFronzo, Bromocriptine: a novel approach to the treatment of type 2 diabetes. Diabetes Care 23(8), 1154\u20131161 (2000)","journal-title":"Diabetes Care"},{"issue":"2","key":"1438_CR161","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1530\/EJE-11-0076","volume":"165","author":"K Berinder","year":"2011","unstructured":"K. Berinder, O. Akre, F. Granath, A.L. Hulting, Cancer risk in hyperprolactinemia patients: a population-based cohort study. Eur. J. Endocrinol. 165(2), 209\u2013215 (2011). https:\/\/doi.org\/10.1530\/EJE-11-0076","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1438_CR162","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1023956223037","volume":"79","author":"K Liby","year":"2003","unstructured":"K. Liby, B. Neltner, L. Mohamet, L. Menchen, N. Ben-Jonathan, Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth. Breast Cancer Res. Treat. 79(2), 241\u2013252 (2003)","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"1438_CR163","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/bjc.1975.243","volume":"32","author":"CW Welsch","year":"1975","unstructured":"C.W. Welsch, G. Louks, D. Fox, C. Brooks, Enhancement by prolactin of carcinogen induced mammary cancerigenesis in the male rat. Br. J. Cancer. 32(4), 427\u2013431 (1975)","journal-title":"Br. J. Cancer."},{"issue":"3","key":"1438_CR164","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/00313029700169205","volume":"29","author":"I Strungs","year":"1997","unstructured":"I. Strungs, R.A. Gray, H.B. Rigby, G. Strutton, Two case reports of breast carcinoma associated with prolactinoma. Pathology 29(3), 320\u2013323 (1997)","journal-title":"Pathology"},{"issue":"3","key":"1438_CR165","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00309236","volume":"23","author":"S Haga","year":"1993","unstructured":"S. Haga, O. Watanabe, T. Shimizu, T. Iida, H. Imamura, T. Kajiwara, M. Fujibayashi, Breast cancer in a male patient with prolactinoma. Surg. Today 23(3), 251\u2013255 (1993)","journal-title":"Surg. Today"},{"issue":"6","key":"1438_CR166","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/BF03351047","volume":"24","author":"F Forloni","year":"2001","unstructured":"F. Forloni, M. Giovilli, C. Pecis, E. Bortolani, A. Preziosi, M.E. Barzaghi, D. Corti, P. Beck-Peccoz, Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male. J. Endocrinol. Invest. 24(6), 454\u2013459 (2001). https:\/\/doi.org\/10.1007\/BF03351047","journal-title":"J. Endocrinol. Invest."},{"issue":"12","key":"1438_CR167","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1200\/JCO.2006.07.6356","volume":"25","author":"SS Tworoger","year":"2007","unstructured":"S.S. Tworoger, A.H. Eliassen, P. Sluss, S.E. Hankinson, A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J. Clin. Oncol. 25(12), 1482\u20131488 (2007). https:\/\/doi.org\/10.1200\/JCO.2006.07.6356","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"1438_CR168","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1158\/0008-5472.CAN-04-1870","volume":"64","author":"SS Tworoger","year":"2004","unstructured":"S.S. Tworoger, A.H. Eliassen, B. Rosner, P. Sluss, S.E. Hankinson, Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res. 64(18), 6814\u20136819 (2004). https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1870","journal-title":"Cancer Res."},{"issue":"1","key":"1438_CR169","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12020-014-0377-9","volume":"48","author":"D Iacovazzo","year":"2015","unstructured":"D. Iacovazzo, L. De Marinis, Treatment of hyperprolactinemia in post-menopausal women: pros. Endocrine 48(1), 76\u201378 (2015). https:\/\/doi.org\/10.1007\/s12020-014-0377-9","journal-title":"Endocrine"},{"issue":"3","key":"1438_CR170","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12020-014-0259-1","volume":"47","author":"I Shimon","year":"2014","unstructured":"I. Shimon, M. B., J. Shapiro, G. Tsvetov, C. Benbassat, A. Barkan, Women with prolactinomas presented at the postmenopausal period. Endocrine 47(3), 889\u2013894 (2014)","journal-title":"Endocrine"},{"issue":"8","key":"1438_CR171","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1210\/jc.2007-0836","volume":"92","author":"JA Schlechte","year":"2007","unstructured":"J.A. Schlechte, Long-term management of prolactinomas. J. Clin. Endocrinol. Metab. 92(8), 2861\u20132865 (2007). https:\/\/doi.org\/10.1210\/jc.2007-0836","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"1438_CR172","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9378(77)90097-7","volume":"129","author":"FI Reyes","year":"1977","unstructured":"F.I. Reyes, J.S. Winter, C. Faiman, Pituitary\u2013ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am. J. Obstet. Gynecol. 129(5), 557\u2013564 (1977)","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"1438_CR173","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/09513599709152546","volume":"11","author":"LA Balint-Peric","year":"1997","unstructured":"L.A. Balint-Peric, G.M. Prelevic, Changes in prolactin levels with the menopause: the effects of estrogen\/androgen and calcitonin treatment. Gynecol. Endocrinol. 11(4), 275\u2013280 (1997)","journal-title":"Gynecol. Endocrinol."},{"issue":"3","key":"1438_CR174","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1210\/jcem.83.3.4675","volume":"83","author":"L Katznelson","year":"1998","unstructured":"L. Katznelson, P.N. Riskind, V.C. Saxe, A. Klibanski, Prolactin pulsatile characteristics in postmenopausal women. J. Clin. Endocrinol. Metab. 83(3), 761\u2013764 (1998). https:\/\/doi.org\/10.1210\/jcem.83.3.4675","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1438_CR175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2265.2001.01190.x","volume":"54","author":"S Karunakaran","year":"2001","unstructured":"S. Karunakaran, R.C. Page, J.A. Wass, The effect of the menopause on prolactin levels in patients with hyperprolactinaemia. Clin. Endocrinol. 54(3), 295\u2013300 (2001)","journal-title":"Clin. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1438-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1438-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1438-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T07:46:04Z","timestamp":1659944764000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1438-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,24]]},"references-count":175,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1438"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1438-7","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,24]]}}}